Local Treatment in the Management of Oligometastatic Prostate Cancer
- Retrospective studies report a survival benefit for local treatment in metastatic prostate cancer (mPCa) patients.
- First data from a randomized trial does not show a survival benefit for the addition of external beam radiotherapy to androgen deprivation treatment in mPCa.
- Local tumor treatment in patients with mPCa should only be offered within trials.









.png)






